Atlas Trials

Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma

Clinical trial NCT04998552 · RECRUITING

Trial details

NCT number
NCT04998552
Sponsor
Capital Health System, Inc
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreas Adenocarcinoma
Start date
2021-06-22
Primary completion
2027-06-22
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.